Granite Point Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Granite Point Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-81,475	Closed	-$1.05M	–	116
2016 Q2	$1.05M	Buy	+81,475	New	+$1.28M	0.45%	40
2015 Q4	$1.52M	Sell	67,500 -132,500	-66%	-$2.62M	0.23%	27
2015 Q3	$4.68M	Buy	200,000 +100,796	+102%	+$2.78M	3.21%	6
2015 Q2	$2.84M	Buy	99,204 +19,204	+24%	+$503K	0.83%	14
2015 Q1	$2.07M	Sell	80,000 -10,000	-11%	-$229K	0.76%	24
2014 Q4	$1.67M	Sell	90,000 -10,000	-10%	-$180K	0.78%	25
2014 Q3	$1.55M	Buy	+100,000	New	+$1.51M	0.77%	22

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Granite Point Capital Management's XENT Position: Q3 2016 in Review

Granite Point Capital Management sold out of Intersect ENT, Inc (XENT) in Q3 2016, closing a stake of 81,475 shares — an estimated $1.05M sold.

Granite Point Capital Management first reported a position in XENT in Q3 2014 and held it in 7 quarters. The position peaked at $4.68M in Q3 2015. 98 funds tracked by Wall St. Rank hold XENT as of Q3 2016.

Granite Point Capital Management reported no remaining Intersect ENT, Inc position as of Q3 2016 after selling out during the quarter.
Granite Point Capital Management sold 81,475 Intersect ENT, Inc shares in Q3 2016, an estimated $1.05M.
Granite Point Capital Management first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 7 quarters.
Granite Point Capital Management's Intersect ENT, Inc position peaked at $4.68M in Q3 2015.
98 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2016.

Based on Granite Point Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.